News

The Inspire 3 will be available worldwide in September, while the higher-end Versa 4 and Sense 2 will be available in the fall.

Dozee's sensor-based technology uses AI to track vital parameters.

Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.

Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.

The newly public company, now trading on Nasdaq under the ticker symbol "AKLI," will use the proceeds from the transaction to launch EndeavorRx, its video game-like digital therapeutic for children with ADHD.

One of the projects will develop a digital navigator to support people with chronic conditions.

It will be used to accelerate collaborations with pharmaceutical firms.

It will use its latest funds for its global expansion.